Human Vaccines Market by Vaccine Type (Conjugate Vaccines, Inactivated or Killed Vaccines, Live Attenuated Vaccines, Synthetic Vaccines, Others), Disease Type (Hepatitis, Human Papilloma Virus, Influenza, Pneumonia, Others) and Forecast 2017-2021

Human Vaccines Market by Vaccine Type (Conjugate Vaccines, Inactivated or Killed Vaccines, Live Attenuated Vaccines, Synthetic Vaccines, Others), Disease Type (Hepatitis, Human Papilloma Virus, Influenza, Pneumonia, Others) and Forecast 2017-2021

Human vaccines are dead or inactivated organisms or purified products derived from them. There are several types of vaccines currently in use. These represent different strategies used to try to reduce risk of illness, while retaining the ability to induce a beneficial immune response. A conjugate vaccine is created by covalently attaching a poor antigen to a strong antigen thereby eliciting a stronger immunological response to the antigen, such as a polysaccharide that is attached to strong protein antigen. Inactivated vaccines are produced by killing the disease-causing microbe with chemicals, heat, or radiation. Such vaccines are more stable and safer than live vaccines. Live, attenuated vaccines contain a version of the living microbe that has been weakened in the lab so it can’t cause disease. Instead of the entire microbe, subunit vaccines include only the antigens that best stimulate the immune system. Synthetic vaccine mainly consists of synthetic peptides, carbohydrates, or antigens, and they are usually considered to be safer than vaccines from bacterial cultures. New safe and effective vaccines are being developed for a variety of infections and parasites against which no effective preventive intervention measure is either available or practical.

The global human vaccines market segmentation is based on vaccine type (conjugate vaccines, inactivated or killed vaccines, live attenuated vaccines, synthetic vaccines, others), and disease type (hepatitis, human papilloma virus, influenza, pneumonia, others).

The global human vaccines market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global human vaccines market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global human vaccines market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global human vaccines market and profiled in this report include Bavarian Nordic, BioMérieux, Crucell, CSL Limited, Eli Lilly, Emergent BioSolutions, Inc., GlaxoSmithKline plc, Intercell, J&J/Janssen/Crucell, MedImmune, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Regeneron, Sanofi Pasteur, Sanofi-Aventis, Schering-Plough, Takeda Pharmaceutical Limited, and Teva Pharmaceuticals.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Human Vaccines Market

1. Vaccine Type
1.1. Conjugate Vaccines
1.2. Inactivated (Killed) Vaccines
1.3. Live, Attenuated Vaccines
1.4. Synthetic Vaccines
1.5. Others

2. Disease Type
2.1. Hepatitis
2.2. Human Papilloma Virus
2.3. Influenza
2.4. Pneumonia
2.5. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.3. Latin America (Brazil, Mexico, Rest of LA)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World (Middle East & Africa)

4. Company Profiles
4.1. Bavarian Nordic
4.2. BioMérieux
4.3. CSL Limited
4.4. Eli Lilly
4.5. Emergent BioSolutions, Inc.
4.6. GlaxoSmithKline plc
4.7. Intercell
4.8. J&J/Janssen/Crucell
4.9. MedImmune
4.10. Merck & Co., Inc.
4.11. Novartis AG
4.12. Pfizer, Inc.
4.13. Regeneron
4.14. Sanofi Pasteur
4.15. Schering-Plough
4.16. Takeda Pharmaceutical Limited
4.17. Teva Pharmaceuticals

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*